Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019

SELL
$0.73 - $2.1 $14,240 - $40,966
-19,508 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$0.63 - $1.12 $38,607 - $68,635
-61,282 Reduced 75.85%
19,508 $14,000
Q3 2018

Nov 13, 2018

SELL
$0.92 - $1.43 $12,381 - $19,244
-13,458 Reduced 14.28%
80,790 $79,000
Q2 2018

Aug 14, 2018

BUY
$0.76 - $1.48 $41,843 - $81,484
55,057 Added 140.48%
94,248 $110,000
Q1 2018

May 15, 2018

BUY
$0.83 - $2.79 $27,674 - $93,026
33,343 Added 570.16%
39,191 $33,000
Q4 2017

Feb 14, 2018

BUY
$2.16 - $3.35 $12,631 - $19,590
5,848
5,848 $13,000

Others Institutions Holding DARE

About Dare Bioscience, Inc.


  • Ticker DARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,820,896
  • Market Cap $28.8M
  • Description
  • Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...
More about DARE
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.